Sign in

    Jon DeCourcey

    Research Analyst at BTIG

    Jon DeCourcey is a seasoned equity research analyst and investor relations executive best known for his specialization in the cannabis sector, where he has held a series of senior analyst roles. At BTIG, Viridian Capital Advisors, and Canaccord Genuity, he directly covered major U.S. and Canadian cannabis companies, consistently providing industry insights and analysis highly regarded by institutional investors. DeCourcey later transitioned to investor relations leadership roles at Ayr Wellness and, most recently, Glass House Brands, leveraging years of sector-specific expertise; his strong analytical track record and intimate sector knowledge have made him a frequent point of reference for cannabis capital markets. He holds professional securities credentials suitable for his roles, though specific FINRA details and performance metrics such as analyst rankings or published investment returns have not been publicly disclosed.

    Jon DeCourcey's questions to Jushi Holdings (JUSHF) leadership

    Jon DeCourcey's questions to Jushi Holdings (JUSHF) leadership • Q4 2022

    Question

    Jon DeCourcey of BTIG asked about the impact of Missouri's adult-use cannabis launch on Jushi's stores in Illinois, particularly near St. Louis, and the strategies being used to mitigate any negative effects.

    Answer

    CEO Jim Cacioppo acknowledged a drag on Illinois sales, similar to what peers experienced. He outlined a mitigation strategy that includes offering more competitive after-tax pricing, leveraging a superior product selection, and significantly cutting store labor costs. He expressed confidence that strong growth in other markets like Virginia, combined with new store openings, would help the company return to peak revenue levels later in the year.

    Ask Fintool Equity Research AI

    Jon DeCourcey's questions to Glass House Brands (GLASF) leadership

    Jon DeCourcey's questions to Glass House Brands (GLASF) leadership • Q4 2022

    Question

    Jon DeCourcey of BTIG asked for more color on the timing of the announced expansion project and its expected contribution to results, the ramp-up period from construction to full production, the drivers behind recent price improvements, and the potential impact of severe weather on outdoor cannabis supply.

    Answer

    Kyle Kazan (Co-Founder, Chairman and CEO) and Mark Vendetti (CFO) clarified that they plan to have plants in the new greenhouse by the end of the year, with revenue contributions likely starting in Q1 2024, and that this is not included in current guidance. Graham Farrar (Co-Founder and President) explained the retrofit would take a couple of quarters, noting that existing nursery and processing infrastructure will accelerate the ramp-up. Farrar also attributed price improvements to both market rationalization and Glass House's consistent high quality, and noted that while the heavy rains are a minor annoyance for their greenhouses, they could be devastating for outdoor cultivators.

    Ask Fintool Equity Research AI